Article
Mendelian randomization study supports the causal association between serum cystatin C and risk of diabetic nephropathy
17 Nov 2022
Abstract excerpt
Aims Cystatin C, an inhibitor of cysteine protease, has been used as a biomarker for estimating glomerular filtration rate. However, the causal relation between cystatin C and diabetic nephropathy remains uncertain. Methods We assessed the causal effect of cystatin C together with other five serum biomarkers including KIM-1, GDF-15, TBIL, uric acid, and Scr on diabetic nephropathy by Mendelian randomization (MR)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
